top of page

Frequency Therapeutics Closes $62MM Series C Financing

Congratulations to Frequency Therapeutics!

They have announced the close of their $62mm Series C financing to expand research of their innovative drug candidate for hearing restoration and its potential for other degenerative diseases using their first-in-class Progenitor Cell Activation platform.

Featured Posts
Recent Posts
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • LinkedIn Social Icon
bottom of page